Advertisement Boveran Diagnostics names new board advisory member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Boveran Diagnostics names new board advisory member

Boveran Diagnostics, which develops cancer detection technologies, has added Kary Mullis to its board of advisors.

Dr Mullis is currently a distinguished researcher at Children’s Hospital and Research Institute in Oakland, California.

Dr Mullis has received a Nobel Prize in chemistry in 1993 for his invention of the polymerase chain reaction. Dr Mullis was also awarded an honorary doctor of science degree from the University of Bologna, Italy.